Morepen Laboratories quarterly results and financials

Morepen Laboratories (MOREPENLAB)₹99.15+5.00%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Sep 2026 quarter (consolidated), Morepen Laboratories reported sales of ₹747 Cr, up 80.9% from Sep 2025, and net profit of ₹88.96 Cr, up 117.0% year on year. For the year to Mar 2026, sales were ₹1,808 Cr and net profit ₹95.89 Cr.

Sales (Sep 2026): ₹747 Cr
Net profit (Sep 2026): ₹88.96 Cr
Sales (FY Mar 2026): ₹1,808 Cr
Net profit (FY Mar 2026): ₹95.89 Cr
EPS (Sep 2026): ₹1.61
Borrowings (Mar 2026): ₹208 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Morepen Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Morepen Laboratories Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	446	424	456	439	454	467	426	413	485	486	571	747
Expenses	394	375	404	394	417	424	401	381	438	460	488	623
Operating Profit	51.02	48.04	52.04	44.03	36.01	42.03	24.02	31.02	46.01	24.01	82.97	123
OPM %	11.1%	11.1%	11.1%	10.0%	8.0%	9.1%	6.0%	7.1%	10.0%	5.0%	14.1%	16.1%
Other Income	3.99	3.99	2.99	5.01	4.99	4.99	4.01	30.02	3.99	7.99	4.99	9.01
Interest	2.01	1.01	1.01	1.01	1.01	5.01	4.01	4.01	4.01	4.01	5.01	5.01
Depreciation	8.02	10.03	6.02	2.01	5.02	16.03	9.03	11.03	10.03	6.02	8.02	10.03
Profit before tax	43.98	41.98	47.99	45.97	35.01	25.99	15.99	46.03	35.02	23.02	74.99	117
Tax %	27.0%	32.0%	25.0%	24.0%	24.0%	21.0%	26.0%	10.0%	22.0%	33.0%	24.0%	24.0%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	22.95	0.00	0.00	0.00	0.00
Net Profit	31.96	28.96	35.98	34.98	26.97	19.98	10.99	40.99	27.97	15.98	55.93	88.96
EPS (Rs)	0.62	0.54	0.70	0.63	0.48	0.36	0.19	0.74	0.49	0.28	1.02	1.61

Morepen Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Morepen Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	486	596	609	771	854	1,191	1,551	1,420	1,694	1,814	1,808	2,289
Expenses	424	534	542	701	785	1,070	1,410	1,339	1,531	1,637	1,680	2,010
Operating Profit	62.03	60.99	65.06	68.02	69.04	119	137	80.01	159	174	126	276
OPM %	13.1%	10.1%	11.1%	9.1%	8.1%	10.0%	9.1%	6.1%	9.1%	10.1%	7.0%	12.1%
Other Income	−2.99	4.01	3.99	3.99	8.99	12.01	9.99	6.01	13.99	17.99	46.99	25.98
Interest	10.01	8.01	4.01	2.01	2.01	2.01	−7.01	2.01	4.01	8.01	16.02	18.04
Depreciation	35.07	34.09	34.09	40.08	37.10	30.08	28.06	28.08	33.09	29.06	36.11	34.10
Profit before tax	13.01	24.01	30.01	28.99	38.98	99.03	127	55.99	135	155	120	250
Tax %	−1.0%	0.0%	0.0%	1.0%	14.0%	1.0%	20.0%	31.0%	29.0%	24.0%	20.0%	—
Exceptional items	−3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	30.94	0.00
Net Profit	12.99	23.98	29.96	28.98	33.98	96.92	102	38.96	96.87	118	95.89	189
EPS (Rs)	0.27	0.52	0.65	0.63	0.74	2.15	2.12	0.75	1.87	2.14	1.72	3.40
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	9.0%	12.0%	—

Morepen Laboratories balance sheet

₹ crore, at each year end.

Morepen Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	89.59	89.61	89.64	89.65	89.65	89.69	89.63	95.68	102	102	110	110
Reserves	78.02	91.09	106	136	163	194	335	483	652	745	1,047	1,137
Borrowings	202	187	169	134	132	133	17.04	19.05	25.05	29.07	105	208
Other Liabilities	121	155	172	225	229	245	415	472	331	415	515	480
Total Liabilities	489	523	538	585	614	662	857	1,069	1,109	1,291	1,776	1,934
Fixed Assets	322	297	272	264	236	216	225	252	267	307	489	513
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	2.01	14.04	17.05	24.05	28.08	22.07
Investments	0.00	0.00	0.00	0.00	0.00	0.99	0.99	0.00	0.00	0.99	85.01	124
Other Assets	167	227	266	320	378	445	630	803	826	958	1,173	1,276
Inventories	37.01	42.04	65.07	77.05	93.98	138	175	276	229	249	300	272
Trade receivables	56.01	88.03	92.96	122	134	138	182	251	263	325	325	333
Cash & equivalents	8.98	3.99	7.97	5.98	31.91	38.92	67.83	45.86	55.88	51.88	48.86	68.78
Total Assets	489	523	538	585	614	662	857	1,069	1,109	1,291	1,776	1,934

Morepen Laboratories cash flow

₹ crore, for each year.

Morepen Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	51.05	49.99	41.02	63.04	17.01	10.99	51.04	−59.98	−90.96	73.02	32.03	33.02
Cash from investing activity	−31.93	−26.93	−13.97	−26.95	−12.97	−11.98	−69.79	−31.90	−46.86	−82.86	−321	−126
Cash from financing activity	−19.07	−27.07	−24.08	−38.12	0.00	5.01	47.10	66.14	144	5.02	301	97.22
Net cash flow	0.00	−4.01	3.01	−1.01	4.01	4.01	28.06	−26.08	6.02	−5.02	10.03	4.01
Capex	4.99	9.99	10.01	26.99	12.01	17.01	40.04	67.07	46.04	81.08	214	161
Free cash flow	45.88	40.87	30.89	36.90	5.98	−5.98	9.96	−127	−137	−7.97	−182	−127
CFO / OP %	105.1%	81.1%	66.1%	98.0%	26.0%	25.0%	44.0%	−25.9%	−94.0%	70.0%	40.1%	46.0%

Morepen Laboratories ratios

Working-capital days and returns, by year.

Morepen Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	51	66	57	73	64	59	56	59	68	70	65	67
Inventory days	54	50	64	75	68	90	81	95	86	84	93	87
Days payable	126	140	125	173	124	113	98	90	87	101	114	103
Cash conversion cycle	−20	−23	−3	−24	9	37	40	65	69	54	45	53
Working capital days	−20	−10	−86	−62	−34	−8	17	55	98	94	107	118
ROCE %	3.0%	8.0%	9.0%	9.0%	8.0%	10.0%	23.0%	22.9%	8.0%	17.0%	15.0%	8.0%

Morepen Laboratories: frequently asked questions

What are the latest quarterly results of Morepen Laboratories?

For the Sep 2026 quarter, Morepen Laboratories reported sales of ₹747 Cr, up 80.9% year on year and net profit of ₹88.96 Cr, up 117.0% year on year. The operating margin was 16.1%.

What is the annual revenue of Morepen Laboratories?

Morepen Laboratories' sales for the year to Mar 2026 were ₹1,808 Cr; over the last twelve months they were ₹2,289 Cr.

What is the net profit of Morepen Laboratories?

Net profit for the year to Mar 2026 was ₹95.89 Cr, and ₹189 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.40.

How much debt does Morepen Laboratories have?

Morepen Laboratories reported borrowings of ₹208 Cr at Mar 2026, against cash and equivalents of ₹68.78 Cr.

What is the free cash flow of Morepen Laboratories?

Cash from operations was ₹33.02 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹127 Cr.

Loading…